angioG Cancer Research Results

angioG, angiogenesis: Click to Expand ⟱
Source:
Type:
Process through which new blood vessels.
Angiogenesis, the process of new blood vessel formation from pre-existing vessels, plays a crucial role in cancer progression and metastasis. Tumors require a blood supply to grow beyond a certain size and to spread to other parts of the body.
Vascular Endothelial Growth Factor (VEGF): VEGF is one of the most important pro-angiogenic factors. It stimulates endothelial cell proliferation and migration, leading to the formation of new blood vessels. Many tumors overexpress VEGF, which correlates with poor prognosis.
Hypoxia-Inducible Factor (HIF): In response to low oxygen levels (hypoxia), tumors can activate HIF, which in turn promotes the expression of VEGF and other angiogenic factors. This mechanism allows tumors to adapt to their microenvironment and sustain growth.
-Tumour development and progression beyond a size of few millimetres‐cubed crucially depends on the onset of angiogenesis, that is, the ‘angiogenic switch’


Scientific Papers found: Click to Expand⟱
7365- HibSad,    Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L
- Review, Var, NA
chemoPv↑, selectivity↑, TumCCA↑, Apoptosis↑, TumAuto↑, TumMeta↓, ATG5↑, Beclin-1/ATG6↑, LC3II↑, MMP2↓, MMP9↓, CD31/PECAM-1↓, VEGF↓, uPA↓, TIMP2↑, NF-kB↓, p38↑, P53↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓, BAX↑, Cyt‑c↑, TNF-α↑, Fas↑, FasL↑, JNK↑, cJun↑, angioG↓, VEGFR2/KDR/Flk1↓, PCNA↓, CCN2/CTGF↓, RAGE↓,
7341- Hne,    Preclinical evaluation of safety and potential of black hellebore extracts for cancer treatment
- Review, Var, NA
angioG↓, TumCP↓, *Inflam↓, *Bacteria↓, *glucose↓, *neuroP↓, *hepatoP↓, *Imm↝,
2885- HNK,    Honokiol: a novel natural agent for cancer prevention and therapy
- Review, Var, NA
NF-kB↓, STAT3↓, EGFR↓, mTOR↓, BioAv↝, Inflam↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, cSrc↓, JAK1↓, JAK2↓, ERK↓, Akt↓, PTEN↑, ChemoSen↑, chemoP↑, COX2/PTGS2↓, PGE2↓, TNF-α↓, IL1β↓, IL6↓, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, DNAdam↑, Cyt‑c↑, RadioS↑, RAS↓, BBB↑, BioAv↓, Half-Life↝, Half-Life↝, toxicity↓,
2894- HNK,    Pharmacological features, health benefits and clinical implications of honokiol
- Review, Var, NA - Review, AD, NA
*BioAv↓, *neuroP↑, *BBB↑, *ROS↓, *Keap1↑, *NRF2↑, *Casp3↓, *SIRT3↑, *Rho↓, *ERK↓, *NF-kB↓, angioG↓, RAS↓, PI3K↓, Akt↓, mTOR↓, *memory↑, *Aβ↓, *PPARγ↑, *PGC-1α↑, NF-kB↓, Hif1a↓, VEGF↓, HO-1↓, FOXM1↓, p27/CDKN1B↑, P21↑, CDK2↓, CDK4↓, CDK6↓, cycD1/CCND1↓, Twist↓, MMP2↓, Rho↑, ROCK1↑, TumCMig↓, cFLIP↓, BMPs↑, OCR↑, ECAR↓, *AntiAg↑, *cardioP↑, *antiOx↑, *ROS↓, P-gp/ABCB1↓,
7469- Hops,    CHEMOPREVENTIVE PROPERTIES OF SPENT HOPS (HUMULUS LUPULUS L.) EXTRACT AGAINST ANGIOGENESIS, INVASION AND MIGRATION OF COLORECTAL CANCER CELLS
- in-vitro, CRC, SW48 - in-vitro, CRC, HT29
angioG↓, TumCI↓, TumCMig↓, MMP2↓, MMP9↓, VEGF↓, Hif1a↓, chemoPv↑,
4640- HT,    The anti-cancer potential of hydroxytyrosol
- Review, Var, NA
selectivity↑, MMP↓, Cyt‑c↑, Casp9↑, Casp3↑, Bcl-2↓, BAX↑, MPT↑, Fas↑, PI3K↓, Akt↓, mTOR↓, Mcl-1↓, survivin↓, STAT3↓, EMT↓, TumCI↓, angioG↓, E-cadherin↑, N-cadherin↓, Snail↓, Twist↓, MMPs↓, MMP2↓, MMP9↓, VEGF↓, VEGFR2/KDR/Flk1↓, Hif1a↓, CSCs↓, CD44↓, Wnt↓, β-catenin/ZEB1↓,
4642- HT,    Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways
- in-vitro, HCC, HepG2 - NA, NA, Hep3B - NA, NA, SK-HEP-1
TumCP↓, TumCCA↑, Apoptosis↑, Akt↓, NF-kB↓, TumCG↓, angioG↓,
7717- IP6,    In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor
- in-vivo, Pca, DU145
TumCG↓, IGFBP3↑, VEGF↓, TumCP↓, angioG↓,
7723- IP6,    Prostate cancer and inositol hexaphosphate: efficacy and mechanisms
- Review, Pca, NA
toxicity↓, AntiCan↑, TumCG↓, TumCCA↑, angioG↓,
7691- IP6,    Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
- vitro+vivo, Pca, PC3 - in-vitro, Pca, C4-2B
TumCP↓, Apoptosis↑, Casp3↑, cl‑PARP↑, Akt↓, PI3K↓, p‑GSK‐3β↓, cycD1/CCND1↓, TumVol↓, TumW↓, PCNA↓, angioG↓, CD31/PECAM-1↓, ILK↓, VEGF↓, eNOS↓, Hif1a↓,
7750- ISL,    Isoliquiritigenin in Breast Cancer: A Systematic Review of Its Preventive and Anti-metastatic Mechanisms
- Review, BC, NA
AntiCan↑, Apoptosis↑, TumAuto↑, mTOR↓, AApath↓, EMT↓, BRCA1↝, PI3K↓, Akt↓, angioG↓, VEGF↓, Hif1a↓, COX2/PTGS2↓, NF-kB↓,
7749- ISL,    Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1
- in-vitro, GBM, U87MG
angioG↓, COX2/PTGS2↓, mPGES-1↓, CYP4A/CYP4A11/CYP4A22↓, FGF21↓, TGF-β↓, VEGF↓, miR-194↑, NEAT1↓,
7756- ISL,    Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, MDA-MB-231
AntiCan↑, VEGF↓, TumCI↓, TumCMig↓, Hif1a↓, TumCG↓, angioG↓, VEGFR2/KDR/Flk1↓, Apoptosis↑, toxicity↓, TumCCA↑, Inflam↓, ROS↑,
7778- ISL,    Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors
- Study, Park, NA - Study, AD, NA
*neuroP?, TumCP↓, *Inflam↓, *hepatoP↑, angioG↓, *AntiBio↑, *AntiDiabetic↓, *ROS↓, *antiOx↑, *MAOA↓, *MAOB↓,
9252- ISO, IH,    Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery
- Review, Var, NA
TumCP↓, Apoptosis↑, Casp↑, mtDam↑, MMPs↓, VEGF↓, EMT↓, *antiOx↓, *Inflam↓, *ROS↓, MDR1↓, PI3K↓, Akt↓, MAPK↓, NF-kB↓, Ingr↝, TumCCA↑, CycB/CCNB1↓, CDK1↓, P21↑, ROS↑, AMPK↑, *Ferroptosis↓, *NRF2↑, *HO-1↑, *IronCh↑, *lipid-P↓, *GSH↑, *ACSL4↓, *COX2/PTGS2↓, VEGF↓, angioG↓, E-cadherin↑, N-cadherin↓, uPA↓, *NK cell↑, radioP↑, Imm↑, Neut↑, Eos↑,
7735- isoFl,    Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy
- Review, Var, NA
Risk↓, ChemoSen↑, chemoP↑, RadioS↑, radioP↑, NF-kB↓, DNMTs↓, TumMeta↓, angioG↓, antiOx↑, BioAv↑, toxicity↓,
7730- isoFl,    Anticancer Potential of Isoflavones: A Narrative Overview of Mechanistic Insights and Experimental Evidence from the Past Ten Years
- Review, Var, NA
Apoptosis↑, ROS↓, TumCCA↓, TumCMig↓, TumCI↓, MMP↓, angioG↓, ChemoSen↑, p‑Akt↓, p‑mTOR↓, cl‑PARP↑, cycA1/CCNA1↓, CycB/CCNB1↓, STAT3↓,
7866- isoO,    Orientin and Cancer Suppression: Molecular Mechanisms and Synergistic Effects
- Review, Var, NA
TumCP↓, Apoptosis↑, angioG↓, TumMeta↓, selectivity↑, *toxicity↓, Bax:Bcl2↑, Cyt‑c↑, Diablo↑, Casp9↑, Casp3↑, cl‑PARP↑, DNAdam↑, γH2AX↑, ROS↑, PCNA↓, MMP2↓, MMP9↓, TumCCA↑, cycD1/CCND1↓, CDK4↓, P21↑, NF-kB↓, HH↓, Ki-67↓, COX2/PTGS2↓, TNF-α↓, ChemoSen↑, chemoP↑, eff↑, angioG↓,
9177- ITCs,  SFN,    Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
- Review, Var, NA
CSCs↓, GutMicro↑, Bacteria↓, TumCCA↑, Apoptosis↑, TumAuto↑, angioG↓, TumCI↓, TumMeta↓, NRF2↑, Glycolysis↓, Wnt↓, β-catenin/ZEB1↓, HH↓, NOTCH↓, NK cell↑, EMT↓, angioG↓, BioAv↓, BioAv↑, AntiBio↑, Bacteria↓, HK2↓, PDH↓, OXPHOS↓, AKT1↓, ACC1↓, FASN↓, ACC-α↓, ACLY↓, SREBP1/SREBF1↓, OCT4↓, Nanog↓, YAP/TEAD↓, miR-21↓, miR-29b↓, ALDH1A1↓, miR-140↑, CD44↓, BMI1↓, miR-200c↑, TumCG↓, TumCI↓, TumCMig↓, E-cadherin↑, N-cadherin↓, Vim↓, α-SMA↓, Slug↓, Snail↓, Twist↓, DNAdam⇅, BioAv↓, ChemoSen↑,
9193- ITCs,  PEITC,  BITC,  SFN,    Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research
- Review, Var, NA
Risk↓, TumCCA↑, TumCD↑, selectivity↑, TumCP↓, angioG↓, EMT↓, CSCs↓, NF-kB↓, NOTCH↑, BioAv↑, AntiCan↑, Synergy↑, Polyps↓, ROS↑, compIII↓, ChemoSen↑, RadioS↑, *p‑4E-BP1↓,
2180- itraC,    Repurposing Drugs in Oncology (ReDO)—itraconazole as an anti-cancer agent
- Review, Var, NA
Dose↝, toxicity↝, BioAv↑, Half-Life↝, BioAv↑, Dose↝, HH↓, TumAuto↑, Akt↓, mTOR↓, angioG↓, MDR1↓, TumCP↓, ChemoSen↑,
2179- itraC,    Repurposing itraconazole for the treatment of cancer
- Review, Var, NA
HH↓, angioG↓, TumCCA↑, MDR1↓, P-gp/ABCB1↓, mTOR↓, VEGF↓, Smo↓, Gli1↓, OS↑, PSA↓,
7983- itraC,    Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells
- in-vitro, Nor, HUVECs
angioG↓, VDAC1↓, mt-ATP↓, AMPK↑, mTOR↓, TumCP↓,
8000- itraC,    The anti-cancer effects of itraconazole in epithelial ovarian cancer
- in-vivo, Ovarian, NA
ChemoSen↑, HH↓, mTOR↓, angioG↓, VEGFR2/KDR/Flk1↓,
8001- itraC,    Repurposing itraconazole as an anticancer agent
- Review, Var, NA
*AntiFungal↑, AntiCan↑, P-gp/ABCB1↓, HH↓, mTOR↓, Wnt↓, β-catenin/ZEB1↓, angioG↓, LymphAG↓, ChemoSen↑, OS↑, Gli1↓, Ki-67↓, CSCs↓,
7982- itraC,    Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and Angiogenesis
- in-vitro, Nor, HUVECs - in-vitro, Lung, A549 - in-vitro, Cerv, HeLa - in-vitro, Nor, HEK293
angioG↓, mTOR↓, NPC1L1↓, AMPK↑, VDAC1↓,
7984- itraC,    The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells
- in-vitro, Nor, NA
VEGFR2/KDR/Flk1↓, angioG↓, toxicity↓, mTOR↓,
7991- itraC,    A Phase II Trial of Perioperative Oral Itraconazole for the Management of Low-Risk Basal Cell Carcinoma
- Trial, BCC, NA
Smo↓, Dose↓, TumVol↓, Endoglin↓, angioG↓, toxicity↝, GLI3↓, toxicity↓,
7989- itraC,    Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer
- Trial, NSCLC, NA
Dose↝, TumVol↓, angioG↓, IL1β↓, GM-CSF↓, HH∅, BioAv↝, other↝,
7987- itraC,    Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer
- Trial, Pca, NA
angioG↓, HH↓, Dose↝, PSA↓, CTC↓, other↝, toxicity↝,
8016- itraC,    Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma
- Human, Ovarian, NA
P-gp/ABCB1↓, angioG↓, HH↓, OS↑, Dose↝,
8014- itraC,    Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer
- vitro+vivo, NSCLC, NA
TumCP↓, TumCMig↓, ChemoSen↑, angioG↓, Hif1a↑,
8035- IVM,    Ivermectin and non-parasitic disorders: An update
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
*AntiP↑, angioG↓, *AntiCan↓, mtDam↑, Apoptosis↑, necrosis↑, TumAuto↑, ROS↑, *neuroP↑, *Stroke↝, *cardioP↑,
8031- IVM,    Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment
- Review, Nor, NA
*AntiP↑, Wnt↓, β-catenin/ZEB1↓, PI3K↓, Akt↓, mTOR↓, HH↓, Imm↑, CSCs↓, P-gp/ABCB1↓, Chl↓, angioG↓,
8027- IVM,    Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
- Review, Var, NA
*AntiP↑, TumCD↑, PAK1↑, TumAuto↑, Casp↑, ICD↑, TCF↝, Hippo↓, Akt↓, mTOR↓, angioG↓, CSCs↓, MMP↓, Cyt‑c↑, Apoptosis↑, BAX↑, P53↑, Bcl-2↓, cycE/CCNE↓, cycD1/CCND1↓, CDK2↓, CDK6↓, CDK4↓, YAP/TEAD↓, TFE3↑, mTORC1↓, mitResp↓, OCR↓, compI↓, MMP↓, ROS↑, SOD2↑, ATP↓, eff↓, mitA↓, P-gp/ABCB1↓, TumVol↓,
7896- IVT,  VT,    Molecular targets of vitexin and isovitexin in cancer therapy: a critical review
- Review, Var, NA
chemoPv↑, Dose↝, ACE/ACE1↓, Ca+2↓, *iNOS↓, *COX2/PTGS2↓, *ROS↓, *Stroke↓, Apoptosis↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, TumAuto↑, HSP90↑, ER Stress↑, Hif1a↓, TumMeta↓, angioG↓, Tf↓, MAPK↓, PI3K↓, Akt↓, β-catenin/ZEB1↓, TumCCA↑, FOXO3↓, mTOR↓,
7906- IVT,    Isovitexin accelerates diabetic wound repair via coordinated angiogenesis and collagen remodeling: Mechanistic insights from cellular and streptozotocin-induced SD rat models
- in-vivo, Nor, NA
*Inflam↓, *Wound Healing↑, *angioG↑, *ROS↓, *Apoptosis↓, *PI3K↑, *Akt↑, *eNOS↑,
7961- JG,    Juglone Inhibits Tumor Metastasis by Regulating Stemness Characteristics and the Epithelial-to-Mesenchymal Transition in Cancer Cells both in Vitro and in Vivo
- vitro+vivo, BC, MCF7 - in-vitro, BC, 4T1 - vitro+vivo, CRC, HCT116
EMT↓, CSCs↓, TumMeta↓, Pin1↓, TumCCA↑, angioG↓, Apoptosis↑, BAX↑, Bcl-2↓,
8007- JG,    Juglone reduces growth and migration of U251 glioblastoma cells and disrupts angiogenesis
- in-vitro, GBM, U251
Pin1↓, AntiCan↑, TumCP↓, Apoptosis↑, Casp3↑, TumCMig↓, angioG↓, VEGF↓, CD31/PECAM-1↓, TGF-β1↓,
5120- JG,    Juglone can inhibit angiogenesis and metastasis in pancreatic cancer cells by targeting Wnt/β-catenin signaling
- in-vitro, PC, NA
angioG↓, Wnt↓, VEGF↓,
8085- KAE,    Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
- Review, Var, NA
Apoptosis↑, TumCCA↑, angioG↓, PI3K↓, Akt↓, STAT3↓, AP-1↓, NRF2↓, BioAv↑, Inflam↓, NF-kB↓, TNF-α↓, VEGF↓, BAX↑, Casp↑, Bcl-2↓, P53↑, PTEN↑, hTERT/TERT↓, NRF2↓, ROS↑, DR5↑, ERK↑, CHOP/DDIT3↑, DR4↑, JNK↑, Ki-67↓, ChemoSen↑,
8087- KAE,    Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways
- Review, Var, NA
TumCCA↓, ROS↝, Apoptosis↑, TumCP↑, TumMeta↓, angioG↓, PI3K↓, EMT↓, Snail↓, E-cadherin↓, N-cadherin↓, MMP2↓, Casp9↑, Casp7↑, PARP↑, Apoptosis↑, *ROS↓, Hif1a↓, p‑Akt↓, P53↑, cMyc↓, Glycolysis↓, PKM2↓, miR-339-5p↝, BioAv↓,
8095- KAE,    Kaempferol: A Key Emphasis to Its Anticancer Potential
- Review, Var, NA
*AntiBio↑, *Inflam↓, *AntiTum↓, *antiOx↑, *cardioP↑, *neuroP↑, *AntiDiabetic↑, Risk↓, TumCCA↑, EMT↓, PI3K↓, Akt↓, MMP2↓, Casp3↑, Casp7↑, Casp9↑, PARP↑, *ROS↓, angioG↓, *BioAv↑, BioAv↑, selectivity↑, GLUT1↓, MCT1↓, ROS↓, ROS↑, Trx↓, Cyt‑c↑, MMP↓, miR-21↓, SOCS-3↓, STAT3↓, CDK1↓, CycB/CCNB1↑, HIF-1↓, JAK1↑, PTEN↑,
8072- KAE,    Natural defense against colorectal cancer: the effects of kaempferol on epigenetics, apoptosis, inflammation, oxidative stress, and cell proliferation
- Review, CRC, NA
AntiCan↑, TumCP↓, TumCI↓, Inflam↓, angioG↓, ROS↑, Apoptosis↑, ChemoSen↑, Risk↓, *antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, *neuroP↑, selectivity↑, PUMA↑, Cyt‑c↑, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, NF-kB↓, COX2/PTGS2↓, CC(CDKs/cyclins)↓, TumCCA↑, BioAv↓, Synergy↑, DR4↑, DR5↑, Casp3↑, Casp9↑, Casp7↑, TumCP↓, TumCI↓, TumAuto↑, mtDam↑, P53↑, MAPK↑, *lipid-P↓, *TAC↑, *Catalase↑, *SOD↑, *GPx↑, *NRF2↑,
8075- KAE,  QC,    Systematic review on anticancer potential of Kaempferol and quercetin against lung, breast, and colorectal cancers with emphasis on in vitro and in vivo studies
- Review, Var, NA
tumCV↓, Apoptosis↑, TumCP↓, TumCMig↓, PI3K↓, Akt↓, MAPK↓, NF-kB↓, P53↑, Bcl-2↓, PARP↑, ERK↓, IQGAP3↓, γH2AX↑, cl‑Casp3↑, cl‑Casp9↑, Rho↓, Rac1↓, MMP2↓, MMP9↓, CTSB↓, CTSD↓, O-Glc↓, SERPINH1/HSP47↓, EMT↓, angioG↓, EGF↓, VEGFR2/KDR/Flk1↓, RadioS↑,
8076- KAE,    Kaempferol suppresses prostate cancer metastasis and tumor angiogenesis via disrupting the LIMK1/Cofilin pathway
- in-vivo, Pca, NA
AntiTum↑, TumCP↓, TumCCA↑, VEGF↓, CDK4↓, CDK6↓, LIMK1↓, Cofilin↓, angioG↓,
8081- KAE,    The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer
- Review, BC, NA
*antiOx↓, *Inflam↓, *neuroP↓, *AntiCan↑, DNAdam↓, Casp3↑, Casp9↑, p‑AMT/GCST/T-protein↑, ROS↑, NRF2↑, Apoptosis↑, cl‑PARP↓, BAX↑, Bcl-2↓, TumCCA↓, angioG↓, MMP3↓, MMP9↓, ChemoSen↑, BioAv↓, Glycolysis↓, cl‑PARP↑, Ca+2↑, MMP↓, ER Stress↑, GRP78/BiP↑, CHOP/DDIT3↑, ATF6↑, angioG↓, VEGF↓, Hif1a↓, chemoP↑, *ROS↓, NRF2↑, BioAv↑,
8055- KAE,    Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review
- Review, Var, NA
antiNeop↑, *toxicity↓, TumCCA↑, ROS↑, ER Stress↑, TumAuto↑, Pyro↑, Ferroptosis↑, angioG↓, Imm↝, Synergy↑, ChemoSen↑, MPT↑, MMP↓, mtDam↑, Cyt‑c↑, Bax:Bcl2↑, Fas↑, DR4↑, DR5↑, JNK↑, ERK↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, Ca+2↑, PI3K↓, Akt↓, mTOR↓, AMPK↑, *Ferroptosis↓, *antiOx↑, *NRF2↑, *GPx4↑, *ROS↓, *MDA↓, *i-Iron↓, *xCT/SLC7A11↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, EMT↓, STAT3↓, M2 MC↓, MCP1/CCL2↓, MMP9↓, MMP2↓, TIMP2↓, ChemoSen↑, PKM2↑, Glycolysis↓, CSCs↓, SOX4↓, OCT4↓, CD44↓, Nanog↓, MDR1↓, *GutMicro↑,
8253- LCA,    Licochalcone A, a natural chalconoid isolated from Glycyrrhiza inflata root, induces apoptosis via Sp1 and Sp1 regulatory proteins in oral squamous cell carcinoma
- in-vitro, SCC, HSC4
*AntiTum↑, *angioG↓, *AntiP↑, *antiOx↑, *Bacteria↓, *Inflam↓, tumCV↓, Sp1/3/4↓, p27/CDKN1B↑, P21↑, cycD1/CCND1↓, Mcl-1↓, survivin↓, Apoptosis↑,
8235- LCA,    Anticancer effects of licochalcones: A review of the mechanisms
- Review, Var, NA
mt-Apoptosis↑, TumAuto↑, TumCMig↓, LC3‑Ⅱ/LC3‑Ⅰ↑, ATG5↑, ATG7↑, p62↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, ATG3↑, Beclin-1/ATG6↑, ATG16L1↑, PERK↑, ATF4↑, ATP↓, Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, Bcl-xL↓, Bcl-2↓, BAD↑, BAX↑, Casp3↑, survivin↓, EGFR↓, ERK↓, Akt↓, mtDam↑, MMP↓, Cyt‑c↑, Casp↑, MDM2↓, CycB/CCNB1↓, CDC2↓, CDC25↓, TumCCA↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, Sp1/3/4↓, MMP-10↓, MMP3↓, TumCI↓, Imm↑, PD-L1↓, ROS↑, 4E-BP1↓, eIF2α↓, PI3K↓, mTOR↓, p‑cMET↑, Ca+2↑, RUBCN↓, ATG13↑, TSC1↑, TSC2↑, PRAS40↑, PP2A↑, ULK1/ATG1↑, THEM4/CTMP↑, DR5↑, Fas↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, PKCδ↓, P70S6K↓, VEGF↓, angioG↓, HK2↓, Glycolysis↓, TrxR1↓, APAF1↑, cl‑PARP↑, Bax:Bcl2↑, ABCG2↓, BioEnh↑,

Showing Research Papers: 251 to 300 of 492
Prev Page 6 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 492

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 17,   antiOx⇅, 1,   ARE↓, 1,   Catalase↓, 2,   Catalase↑, 4,   Copper↓, 2,   Fenton↑, 4,   frataxin↑, 1,   GCLC↑, 1,   GPx↑, 4,   GPx4↓, 4,   GSH↓, 28,   GSH↑, 3,   GSH⇅, 1,   GSH/GSSG↓, 1,   GSR↓, 1,   ox-GSSG↑, 1,   GSTs↓, 1,   H2O2↓, 1,   H2O2↑, 4,   HO-1↓, 6,   HO-1↑, 11,   HO-2↓, 1,   Iron↑, 2,   Iron∅, 1,   Keap1↓, 2,   lipid-P?, 1,   lipid-P↓, 4,   lipid-P↑, 16,   MDA↓, 5,   MDA↑, 2,   NOX↓, 1,   NQO1↑, 2,   NRF2↓, 17,   NRF2↑, 20,   Prx↓, 2,   Prx4↑, 1,   PrxI↓, 1,   PrxII↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 1,   ROS↓, 23,   ROS↑, 181,   ROS⇅, 4,   ROS↝, 5,   i-ROS↑, 1,   mt-ROS↑, 5,   SOD↓, 6,   SOD↑, 7,   SOD1↓, 2,   SOD1↑, 1,   SOD2↑, 2,   TAC↑, 1,   TBARS↑, 1,   Thiols↓, 3,   Trx↓, 2,   ox-Trx1↑, 1,   TrxR↓, 6,   TrxR1↓, 2,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

ATOX1↝, 1,   Ferritin↓, 2,   IronCh↑, 2,   NCOA4↑, 1,   Tf↓, 2,   Tf↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR-ABL↓, 1,   CDC2↓, 3,   CDC25↓, 7,   compI↓, 3,   compII↓, 2,   compIII↓, 2,   EGF↓, 5,   ETC↓, 5,   HSP60/HSPD1↓, 2,   mitResp↓, 2,   Mortalin↓, 1,   mtDam↓, 1,   mtDam↑, 19,   OCR↓, 5,   OCR↑, 2,   OXPHOS↓, 4,   OXPHOS↑, 3,   PDH↓, 2,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   VDAC1↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 1,   5LO↓, 4,   AApath↓, 1,   ACC↓, 1,   ACC↑, 1,   ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 1,   ALAT↓, 3,   AMP↓, 1,   AMPK↓, 1,   AMPK↑, 18,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ARG↓, 1,   ATP↓, 15,   mt-ATP↓, 2,   CAIX/CA9↓, 1,   CBS↑, 1,   citrate↓, 1,   CPT1A↓, 1,   CYP4A/CYP4A11/CYP4A22↓, 1,   ECAR↓, 2,   ECAR↝, 1,   ENO1↓, 1,   FABP5/E-FABP↓, 1,   FASN↓, 6,   FASN↑, 1,   GAPDH↓, 1,   GlucoseCon↓, 3,   Glycolysis↓, 32,   GSK‐3β↓, 11,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 4,   Histones↑, 1,   HK2↓, 12,   HMG-CoA↓, 2,   lactateProd↓, 5,   LDHA↓, 4,   LDL↓, 3,   LDL↑, 1,   lipoGen↓, 1,   NADPH↓, 4,   NADPH↑, 2,   NPC1L1↓, 2,   O-Glc↓, 1,   PCK1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 8,   p‑PDK1 / PDPK1↓, 1,   PDK3↑, 1,   PDKs↓, 1,   PFK↓, 2,   PFK1↓, 1,   PFK2?, 1,   PKM2↓, 9,   PKM2↑, 1,   PKM2:PKM1↓, 1,   SIRT1↓, 8,   SIRT1↑, 9,   SIRT2↓, 1,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA↓, 3,   Warburg↓, 6,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 6,   APAF1↑, 6,   Apoptosis?, 1,   Apoptosis↓, 6,   Apoptosis↑, 194,   mt-Apoptosis↑, 3,   ASK1↑, 1,   BAD↓, 2,   BAD↑, 4,   Bak↑, 12,   BAX↓, 3,   BAX↑, 76,   BAX⇅, 1,   Bax:Bcl2↑, 23,   Bcl-2↓, 82,   Bcl-2↑, 2,   Bcl-xL↓, 28,   BID↓, 1,   BID↑, 3,   BIM↓, 1,   BIM↑, 5,   BNIP3↝, 1,   BOK↑, 1,   Casp↓, 2,   Casp↑, 35,   Casp↝, 1,   cl‑Casp↑, 1,   Casp10↑, 1,   Casp12?, 1,   Casp12↑, 1,   cl‑Casp12↑, 1,   Casp2↑, 1,   Casp3?, 1,   Casp3↓, 4,   Casp3↑, 99,   cl‑Casp3↑, 12,   proCasp3↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   Casp8↓, 1,   Casp8↑, 24,   Casp8∅, 1,   cl‑Casp8↑, 3,   proCasp8↑, 1,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 65,   cl‑Casp9↑, 7,   CellShr↑, 2,   cFLIP↓, 3,   Cupro↑, 2,   Cyt‑c↑, 69,   Cyt‑c↝, 2,   Diablo↑, 8,   DR5↑, 22,   FADD↑, 8,   Fas↓, 2,   Fas↑, 18,   FasL↑, 7,   Ferroptosis↑, 12,   GSDME↑, 1,   IAP1↓, 8,   IAP2/BIRC3↓, 5,   ICAD↓, 1,   ICD↑, 1,   iNOS↓, 11,   Mcl-1?, 1,   Mcl-1↓, 29,   MDM2↓, 10,   MDM2↑, 1,   p‑MDM2↓, 1,   MOMP↓, 1,   MOMP↑, 7,   NAIP↓, 1,   Necroptosis↑, 4,   necrosis↑, 3,   NOXA↑, 4,   p38↓, 1,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 2,   Paraptosis↑, 2,   PUMA↑, 6,   Pyro↑, 3,   RIP3↑, 1,   survivin↓, 55,   TNFR 1↑, 2,   TRAIL↑, 2,   TRAIL⇅, 1,   TRAILR↑, 2,   TumCD↑, 17,   XIAP↓, 29,   YAP/TEAD↓, 7,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 126,   Akt↑, 8,   Akt↝, 1,   Akt∅, 1,   p‑Akt↓, 27,   AKT1↓, 3,   Akt2↓, 1,   BRAF↓, 1,   CK2↓, 3,   cMET↓, 3,   p‑cMET↑, 1,   CREB↓, 1,   CREB2↓, 1,   cSrc↓, 1,   DDIT4↑, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 36,   ERK↑, 8,   ERK↝, 2,   ERK∅, 1,   p‑ERK↓, 9,   p‑ERK↑, 1,   FGFR1↓, 2,   FOXD3↑, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   Hippo↓, 1,   Hippo↝, 1,   IGF-1R↓, 3,   IGFR↓, 1,   IKKα↓, 6,   p‑IKKα↓, 1,   ILK↓, 1,   IκB↓, 2,   IκB↑, 1,   p‑IκB↓, 1,   JAK↓, 5,   JAK1↓, 4,   JAK1↑, 1,   JAK2↓, 11,   JNK↓, 3,   JNK↑, 14,   JNK↝, 1,   p‑JNK↓, 2,   LIMK1↓, 1,   MAPK↓, 35,   MAPK↑, 11,   MAPK↝, 1,   MEK↓, 5,   mTOR↓, 77,   mTOR↑, 1,   p‑mTOR↓, 3,   mTORC2↓, 2,   mTORC2↑, 1,   p70S6↓, 1,   p‑p70S6↓, 1,   P70S6K↓, 5,   p‑P70S6K↓, 1,   P90RSK↓, 1,   PDGFR-BB↓, 1,   p‑PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 92,   PI3K↑, 1,   PI3K↝, 1,   p‑PI3K↓, 2,   PI3K/Akt↓, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKCδ↓, 11,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 2,   PTEN↑, 24,   p‑PTEN↓, 1,   Raf↓, 3,   RAS↓, 10,   RIP1↑, 1,   SHP1↑, 1,   Sp1/3/4↓, 16,   STAT↓, 3,   STAT3↓, 61,   STAT3↑, 2,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 2,   STAT5↓, 1,   STAT6↓, 3,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 3,   ATF4↝, 1,   CBP↓, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 35,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 2,   DNMT3B↓, 2,   DNMTs↓, 7,   EZH2↓, 1,   FOXM1↓, 4,   FOXO↑, 1,   FOXO1↓, 2,   FOXO1↑, 1,   FOXO3↓, 5,   FOXO3↑, 6,   FOXO3↝, 1,   p‑FOXO3↓, 2,   H3↓, 2,   p‑H3↓, 1,   ac‑H3↑, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 6,   HATs↑, 2,   HDAC↓, 24,   HDAC1↓, 7,   HDAC2↓, 1,   HDAC3↓, 1,   HDAC4↓, 2,   HDAC6↓, 1,   HDAC8↓, 2,   HES1↓, 2,   miR-106b↓, 1,   miR-107↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-155↓, 1,   miR-194↑, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-218↑, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-339-5p↝, 1,   miR-340↓, 1,   miR-34a↑, 2,   miR-34b-5p↑, 1,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   Myc↓, 5,   MYCN↓, 1,   NDRG1↑, 1,   NEAT1↓, 1,   OCT4↓, 9,   other?, 1,   other↓, 4,   other↑, 4,   other⇅, 1,   other↝, 14,   SOX2↓, 3,   SOX4↓, 1,   SOX4↑, 1,   SOX9↓, 1,   SUV39H↓, 2,   TFE3↑, 1,   tumCV↓, 29,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↑, 17,   COX17↝, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 2,   p‑eIF2α↑, 3,   ER Stress↓, 2,   ER Stress↑, 35,   GRP78/BiP?, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 9,   HSP27↓, 2,   HSP27↑, 1,   HSP27↝, 1,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP90↓, 16,   HSP90↑, 1,   HTRA↓, 2,   PERK↑, 6,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 4,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 2,   ATG5↑, 4,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 10,   CTSB↓, 1,   CTSD↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3B↓, 1,   LC3B-II↑, 3,   LC3II↑, 10,   LC3s↑, 1,   p62↓, 4,   p62↑, 3,   p‑p62↑, 1,   PARK2↑, 1,   RUBCN↓, 1,   SESN2↑, 2,   TumAuto↓, 2,   TumAuto↑, 47,   TumAuto⇅, 1,   TumAuto↝, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 3,   BRCA1↓, 3,   BRCA1↑, 2,   BRCA1↝, 1,   BRCA2↓, 1,   DFF45↓, 1,   DFF45↑, 2,   DNAdam↓, 3,   DNAdam↑, 50,   DNAdam⇅, 1,   DNArepair↓, 6,   DNArepair↑, 1,   m-FAM72A↓, 1,   G9a↓, 1,   hTERT/TERT↓, 11,   MGMT↓, 1,   p16↑, 2,   P53?, 1,   P53↑, 66,   P53↝, 3,   p‑P53↑, 2,   PARP↓, 1,   PARP↑, 16,   cl‑PARP↓, 2,   cl‑PARP↑, 53,   PARP1↑, 1,   cl‑PARP1↑, 1,   PCNA↓, 21,   SIRT6↓, 1,   SIRT6↑, 1,   Telomerase↓, 16,   TOP1↓, 8,   TOP2↓, 6,   TOP2↑, 1,   TP53↑, 3,   TRF2↓, 1,   UHRF1↓, 1,   γH2AX↑, 4,  

Cell Cycle & Senescence(tgid=11) ⓘ

CC(CDKs/cyclins)↓, 1,   CDK1↓, 11,   CDK1↑, 3,   p‑CDK1↓, 2,   CDK2↓, 32,   CDK2↑, 2,   CDK4↓, 35,   CDK4↑, 2,   CDK4/6↓, 1,   CDK6↓, 18,   CDK6↑, 2,   CDK7↓, 1,   CDK8↓, 1,   CHK1↓, 1,   CHK1↑, 2,   Chk2↓, 1,   Chk2↑, 2,   ChrCon↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 7,   CycB/CCNB1↓, 20,   CycB/CCNB1↑, 2,   cycD1/CCND1↓, 56,   CycD3↓, 3,   cycE/CCNE↓, 21,   cycE1↓, 1,   E2Fs↓, 5,   E2Fs↑, 1,   GADD45A↓, 1,   Ki-67↓, 23,   mitA↓, 1,   mitA↑, 1,   p19↑, 1,   P21?, 1,   P21↓, 3,   P21↑, 44,   p27/CDKN1B↑, 19,   pRB↑, 1,   p‑pRB↓, 1,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 5,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 1,   TumCCA↓, 7,   TumCCA↑, 167,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 3,   p‑4E-BP1↓, 1,   ALDH↓, 8,   ALDH1A1↓, 1,   Axin2↑, 1,   BMI1↓, 1,   BMPs↑, 2,   CD133↓, 4,   CD133↑, 1,   CD24↓, 1,   CD34↓, 1,   cFos↓, 6,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 48,   CSCs↑, 2,   Diff↑, 4,   FGF↓, 2,   FGF↑, 1,   Gli↓, 1,   Gli1↓, 5,   HH↓, 11,   HH∅, 1,   HMGCR↓, 1,   IGF-1↓, 10,   IGF-2↓, 1,   IGFBP3↑, 4,   Jun↓, 1,   Ki-67↓, 23,   Let-7↑, 2,   mTORC1↓, 5,   Nanog↓, 7,   Nestin↓, 1,   NICD↓, 1,   NOTCH↓, 12,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↑, 3,   OGF↑, 1,   OGFr↑, 1,   p300↓, 2,   PTCH1↓, 1,   PTCH2↓, 1,   SCF↓, 1,   Shh↓, 4,   Smo↓, 3,   STAT1↓, 1,   TAZ↓, 1,   TumCG↓, 92,   TumCG↑, 1,   TumCP↓, 158,   TumCP↑, 6,   tyrosinase↓, 1,   Wnt↓, 37,   Wnt/(β-catenin)↓, 2,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   annexin II↓, 1,   AntiAg?, 1,   AP-1↓, 8,   ARG1/2↑, 1,   ASAP2↓, 1,   AXL↓, 1,   CA↓, 3,   Ca+2↓, 3,   Ca+2↑, 26,   Ca+2↝, 5,   i-Ca+2↑, 1,   CAFs/TAFs↓, 1,   cal2↓, 1,   Cal9↑, 1,   CCN2/CTGF↓, 1,   Cdc42↓, 1,   Cdc42↑, 1,   Chl↓, 1,   Cofilin↓, 1,   COL1↓, 3,   COL3A1↓, 1,   COL4A3↓, 1,   E-cadherin↓, 5,   E-cadherin↑, 34,   EM↑, 1,   EMT↓, 69,   EMT↑, 2,   EpCAM↓, 3,   F-actin↓, 1,   FAK↓, 18,   p‑FAK↓, 4,   p‑FAK↑, 1,   Fibronectin↓, 3,   GLI2↓, 1,   GLI3↓, 1,   IQGAP3↓, 1,   ITGB1↓, 2,   ITGB3↓, 3,   ITGB6↓, 1,   KRAS↓, 1,   LEF1↓, 1,   MALAT1↓, 2,   MET↓, 1,   MMP-10↓, 2,   MMP1↓, 9,   MMP13↓, 3,   MMP14↓, 1,   MMP16↓, 2,   MMP2?, 1,   MMP2↓, 77,   MMP3↓, 9,   MMP7↓, 9,   MMP9?, 1,   MMP9↓, 97,   MMP9↑, 2,   MMPs↓, 40,   MUC4↓, 2,   N-cadherin↓, 20,   NEDD9↓, 1,   p‑p44↓, 1,   PAK1↓, 1,   PAK1↑, 1,   pax↓, 1,   PDGF↓, 10,   PGF↓, 1,   Rac1↓, 3,   RECK↑, 3,   Rho↓, 5,   Rho↑, 1,   ROCK1↓, 4,   ROCK1↑, 1,   Slug↓, 11,   Smad1↓, 2,   Smad1↝, 1,   p‑SMAD2↓, 1,   SMAD3↓, 2,   p‑SMAD3↓, 1,   Snail?, 1,   Snail↓, 18,   STAC2↓, 1,   TET1↑, 2,   TGF-β↓, 18,   TGF-β↑, 1,   TGF-β↝, 1,   TGF-β1↓, 2,   TIMP1↑, 10,   TIMP2↓, 1,   TIMP2↑, 13,   TIMP3↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TSP-1↑, 9,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 109,   TumCI↑, 1,   TumCMig↓, 82,   TumCMig↑, 3,   TumMeta?, 1,   TumMeta↓, 126,   TumMeta↑, 7,   Twist↓, 18,   TXNIP↑, 1,   uPA↓, 20,   uPAR↓, 3,   Vim↓, 26,   Zeb1↓, 8,   ZEB2↓, 2,   α-SMA↓, 3,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 41,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 449,   angioG↑, 11,   angioG∅, 1,   angioS↑, 1,   CD31/PECAM-1↓, 12,   EGR1↑, 1,   Endoglin↓, 1,   Endoglin↑, 1,   eNOS↓, 3,   HIF-1↓, 11,   Hif1a↓, 83,   Hif1a↑, 1,   Hif1a↝, 1,   Hypoxia↓, 1,   LymphAG↓, 1,   NO↓, 3,   NO↑, 1,   TYMP/ECGF1↓, 1,   VCAM-1↓, 3,   VEGF↓, 183,   VEGF↑, 2,   VEGFR1↓, 5,   VEGFR2/KDR/Flk1↓, 32,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 9,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN2↓, 1,   CTR1↝, 1,   CX43/GJA1↓, 1,   EPR↑, 10,   GLUT1↓, 12,   GLUT2↓, 1,   GLUT4↓, 1,   IBI↑, 1,   MMP↓, 81,   MMP↑, 2,   MMP↝, 1,   MPT↑, 5,   NHE1↓, 2,   OCLN↑, 1,   TJ↑, 1,   TRPV1↑, 2,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CD4+↓, 1,   CD44↓, 15,   CD8+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 71,   COX2/PTGS2↑, 2,   CXCL16↓, 1,   CXCL6/GCP-2↓, 1,   CXCR2↓, 2,   CXCR4↓, 16,   DCells↑, 1,   DR4↑, 9,   Eos↑, 1,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   ICAM-1↓, 9,   IFN-γ↓, 3,   IFN-γ↑, 3,   Igs↑, 1,   IL1↓, 6,   IL10↓, 4,   IL10↑, 2,   IL12↓, 1,   IL12↑, 1,   IL1α↓, 1,   IL1β↓, 15,   IL2↓, 2,   IL2↑, 5,   IL4↓, 2,   IL4↑, 1,   IL6↓, 34,   IL8↓, 9,   Imm↑, 26,   Imm↝, 6,   INF-γ↑, 1,   Inflam↓, 51,   Inflam↝, 1,   LIF↑, 1,   LRIG1↑, 1,   pol-M1↑, 1,   M2 MC↓, 2,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 9,   MCT1↓, 1,   MDSCs↓, 2,   MIP-1β↑, 1,   MIP2↓, 1,   mPGES-1↓, 2,   MyD88↓, 1,   MyD88↑, 1,   NAF1↓, 1,   Neut↑, 1,   NF-kB↓, 144,   NF-kB↑, 3,   NF-kB↝, 2,   p‑NF-kB↓, 2,   p‑NF-kB↑, 2,   NK cell↑, 8,   NLRP3↓, 4,   NLRP3↑, 1,   p50↓, 1,   p65↓, 1,   PD-1↓, 1,   PD-L1↓, 7,   PGE2↓, 17,   PSA↓, 7,   PSA∅, 1,   RAGE↓, 2,   SOCS-3↓, 1,   T-Cell↑, 1,   T-Cell↝, 1,   TCF↓, 3,   TCF↝, 1,   Th1 response↑, 2,   Th17↑, 1,   Th2↑, 1,   TLR4↓, 6,   TLR4↑, 1,   TLR4↝, 1,   TNF-α↓, 35,   TNF-α↑, 3,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   TRADD↑, 1,   TRAF1↓, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

IM↓, 1,   pH↝, 1,   e-pH↑, 1,   i-pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ADRB2↓, 2,   AR↓, 13,   CYP17A1↓, 1,   CYP19↓, 2,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   FGF21↓, 2,   GR↑, 1,   PPARα↓, 2,   PPARα↑, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 4,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   BioAv↓, 53,   BioAv↑, 61,   BioAv↝, 9,   BioEnh↑, 5,   CBR1↓, 1,   chemoR↓, 1,   ChemoSen?, 1,   ChemoSen↓, 1,   ChemoSen↑, 164,   ChemoSen⇅, 1,   ChemoSen∅, 1,   CompStab?, 1,   CompStab↓, 3,   CompStab↑, 1,   CompStab↝, 1,   CYP1A1↓, 2,   CYP1A1↑, 3,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 3,   DDS↑, 5,   Dose?, 5,   Dose↓, 4,   Dose↑, 3,   Dose⇅, 1,   Dose↝, 56,   Dose∅, 8,   DrugR↓, 2,   eff?, 1,   eff↓, 30,   eff↑, 99,   eff↝, 11,   eff∅, 3,   GSTZ1↓, 1,   Half-Life↓, 17,   Half-Life↑, 5,   Half-Life↝, 10,   Half-Life∅, 2,   MDR1↓, 12,   MRP1/ABCC1↓, 3,   NAT↓, 1,   P-gp/ABCB1↓, 20,   P-gp/ABCB1↝, 1,   P450↓, 4,   RadioS?, 2,   RadioS↑, 52,   selectivity?, 1,   selectivity↑, 68,   Synergy?, 1,   Synergy↓, 1,   Synergy↑, 105,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 2,   AFP↑, 1,   ALAT↓, 3,   ALP↓, 3,   AR↓, 13,   ascitic↓, 2,   AST↓, 2,   BloodF⇅, 1,   BRAF↓, 1,   BRCA1↓, 3,   BRCA1↑, 2,   BRCA1↝, 1,   CEC↝, 1,   CIT↓, 1,   CRP↓, 2,   CTC↓, 1,   E6↓, 1,   E7↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 1,   EZH2↓, 1,   Ferritin↓, 2,   FOXM1↓, 4,   HemoG↓, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 11,   IL6↓, 34,   KRAS↓, 1,   LDH↓, 6,   LDH↑, 2,   Maspin↑, 1,   Myc↓, 5,   NOS2↓, 1,   PD-L1↓, 7,   Polyps↓, 1,   PSA↓, 7,   PSA∅, 1,   RAGE↓, 2,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↓, 1,   AntiCan↑, 65,   AntiCan∅, 1,   antiNeop↑, 4,   AntiTum↑, 23,   cardioP↑, 10,   CardioT↓, 1,   CardioT↑, 2,   chemoP↑, 32,   chemoPv↑, 27,   ChemoSideEff↓, 5,   fatigue↓, 3,   fatigue∅, 1,   hepatoP↓, 1,   hepatoP↑, 9,   Mucositis↓, 1,   neuroP↑, 8,   OS↑, 21,   OS∅, 1,   Pain↓, 1,   PFS↑, 1,   Pin1↓, 2,   QoL↑, 8,   QoL∅, 1,   radioP↑, 11,   Remission↑, 3,   RenoP↑, 8,   Risk↓, 22,   Risk↑, 2,   Sleep↑, 1,   toxicity↓, 28,   toxicity↑, 4,   toxicity↝, 11,   toxicity∅, 1,   TumNum?, 1,   TumNum↓, 3,   TumVol↓, 27,   TumVol∅, 1,   TumW↓, 16,   TumW∅, 1,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 7,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 14,  
Total Targets: 1036

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 7,   antiOx↑, 76,   Catalase↑, 26,   DPPH↓, 1,   GPx↑, 20,   GPx1↑, 3,   GPx4↑, 2,   GSH↑, 21,   GSR↑, 3,   GSSG↓, 1,   GSTs↑, 9,   H2O2↓, 2,   HDL↑, 1,   HNE↓, 1,   HO-1↑, 12,   i-Iron↓, 1,   Keap1↓, 1,   Keap1↑, 1,   lipid-P↓, 25,   MDA↓, 13,   MPO↓, 1,   NADH↓, 1,   NOX4↓, 1,   Nrf1↑, 2,   NRF2↑, 25,   RNS↓, 1,   ROS↓, 82,   ROS↑, 2,   ROS∅, 1,   SAM-e↑, 1,   selenoP↑, 1,   SOD↑, 28,   SOD1↑, 3,   SOD2↑, 1,   TAC↑, 3,   TBARS↓, 1,   TOS↓, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 4,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   OXPHOS↓, 1,   PGC-1α↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↓, 4,   5LO↝, 1,   ACSL4↓, 1,   ALAT?, 1,   ALAT↓, 5,   AMPK↓, 1,   AMPK↑, 3,   ATP↑, 1,   ATP↝, 1,   BHB↑, 1,   cytoP450↓, 1,   glucose↓, 5,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 2,   HK2↑, 1,   LDHA↑, 1,   LDL↓, 5,   lipidLev↓, 1,   NAD↝, 1,   NADPH↑, 1,   PFKL↑, 1,   PFKM↑, 1,   PFKP↑, 1,   PKM2↑, 1,   SIRT1↑, 7,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   ASC?, 1,   BAX↓, 3,   Bcl-2↑, 1,   Casp1↓, 1,   Casp3↓, 6,   Casp9↓, 3,   Cyt‑c↓, 2,   Ferroptosis↓, 2,   iNOS↓, 10,   iNOS↑, 1,   p38↓, 3,   Pyro?, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 1,   AKT1↑, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↓, 1,   ERK↑, 2,   JAK2↓, 1,   JNK↓, 1,   JNK↑, 1,   p‑JNK↓, 2,   p‑LIMK1↑, 1,   MAPK↓, 4,   MAPK↑, 2,   p‑MEK↑, 1,   mTOR↓, 1,   mTOR↑, 1,   PDGFR-BB↑, 1,   PI3K↓, 1,   PI3K↑, 2,   PKCδ↑, 1,   Sp1/3/4↓, 1,   STAT3↓, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 5,   ATF4↓, 1,   cMyc↓, 2,   HDAC↓, 1,   OCT4↓, 1,   other↓, 4,   other↑, 5,   other↝, 6,   SOX18↑, 1,   SOX9↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 1,   CHOP/DDIT3↓, 1,   ER Stress↓, 3,   GRP78/BiP↓, 1,   HSP70/HSPA5↑, 2,   HSPs↑, 1,   PERK↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 1,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 1,   GADD45A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   CD133↑, 1,   Diff↑, 1,   FGF↑, 2,   IGF-1↑, 1,   MSCs↑, 1,   neuroG↑, 2,   TumCP↓, 4,   tyrosinase↓, 1,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 8,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 2,   p‑Cofilin↑, 1,   COL1↑, 1,   COL2A1↑, 1,   EMT↓, 1,   FAK↑, 1,   ITGB1↑, 1,   p‑MLC2/MYL9↑, 1,   MMP13↓, 1,   MMP2↓, 2,   MMP2↑, 1,   MMP3↓, 1,   MMP9↓, 2,   MMP9↑, 2,   MYPT1 / PPP1R12A↑, 1,   p‑MYPT1 / PPP1R12A↑, 1,   N-cadherin↑, 1,   Rac1↑, 1,   Rho↓, 1,   ROCK1↑, 1,   serineP↓, 1,   Snail↑, 1,   TGF-β↓, 1,   TGF-β↑, 3,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP2↑, 1,   TumCI↓, 1,   TumCMig↓, 1,   Twist↑, 1,   uPA↓, 1,   Vim↑, 1,   α-SMA↑, 1,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 14,   angioG↑, 28,   angioG↝, 1,   CD31/PECAM-1↑, 1,   E-sel↓, 1,   eNOS↓, 2,   eNOS↑, 2,   Hif1a↓, 2,   Hif1a↑, 4,   NO↓, 8,   NO↑, 2,   VCAM-1↓, 2,   VEGF↓, 8,   VEGF↑, 12,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 6,   CLDN5↑, 1,   GastroP↑, 1,   GLUT1↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   IBI↑, 1,   ketosis↑, 1,   MMP↑, 4,   MMP↝, 1,   MMP∅, 1,   OATPs↓, 1,   VGCC↑, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD8+↑, 1,   COX1↓, 4,   COX2/PTGS2↓, 24,   CXCR4↓, 1,   ICAM-1↓, 2,   IFN-γ↓, 2,   IL1↓, 1,   IL10↓, 2,   IL10↑, 3,   IL12↓, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 12,   IL2↓, 1,   IL4↓, 1,   IL6↓, 16,   IL6↑, 1,   IL8↓, 1,   Imm↑, 6,   Imm⇅, 1,   Imm↝, 1,   Inflam↓, 90,   Inflam↑, 3,   IRF3↓, 2,   MCP1/CCL2↓, 1,   MyD88↓, 2,   NeuroI↓, 1,   NF-kB↓, 22,   NK cell↑, 2,   NLRP3↓, 3,   p65↓, 1,   PGE2↓, 9,   PGE2↑, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR2↓, 3,   TLR4↓, 3,   TLR4∅, 1,   TNF-α↓, 20,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 7,   BChE↓, 1,   BDNF↑, 2,   GABA↑, 2,   GABA↝, 1,   MAOA↓, 1,   MAOB↓, 2,   NGF↑, 1,   TrkB↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 9,   BACE/β-secretase↓, 1,   tau↓, 3,   p‑tau↓, 3,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

Estro↓, 1,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 2,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 30,   BioAv↑, 30,   BioAv⇅, 1,   BioAv↝, 15,   BioAv∅, 1,   BioEnh↑, 2,   CompStab↑, 2,   Dose↑, 1,   Dose⇅, 1,   Dose↝, 9,   Dose∅, 1,   eff↑, 8,   eff↝, 2,   GSTA1↑, 2,   Half-Life↑, 2,   Half-Life↝, 7,   Half-Life∅, 3,   P450↓, 1,   selectivity↑, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 5,   ALP↓, 2,   ascitic↓, 1,   AST↓, 7,   BloodF↑, 1,   BMD↑, 3,   BP↓, 2,   Calcium↑, 1,   creat↓, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 16,   IL6↑, 1,   LDH↓, 4,   Mag↑, 1,   NOS2↓, 1,   TC↓, 1,   Urea↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 3,   antiAll↑, 6,   AntiArt↑, 3,   AntiCan↓, 2,   AntiCan↑, 11,   AntiDiabetic↓, 1,   AntiDiabetic↑, 18,   AntiTum↓, 1,   AntiTum↑, 2,   Bone Healing↑, 1,   cardioP↑, 31,   cardioP⇅, 1,   chemoP↑, 3,   chemoPv↑, 3,   ChemoSideEff↓, 2,   cognitive↓, 1,   cognitive↑, 9,   diuretic↑, 1,   fatigue↓, 1,   hepatoP↓, 1,   hepatoP↑, 26,   memory↑, 12,   Mood↑, 1,   motorD↑, 2,   neuroP?, 1,   neuroP↓, 2,   neuroP↑, 45,   Obesity↓, 6,   OS↑, 1,   Pain↓, 3,   PDE4↓, 1,   radioP↑, 3,   RenoP↑, 5,   Risk↓, 2,   Sleep↑, 1,   Stress↓, 1,   Stroke↓, 3,   Stroke↝, 1,   toxicity↓, 33,   toxicity↑, 3,   toxicity↝, 8,   toxicity∅, 8,   Weight↓, 1,   Wound Healing↑, 5,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 8,   AntiFungal↑, 4,   AntiP↑, 4,   AntiViral↑, 8,   Bacteria↓, 17,   Bacteria↑, 1,   GutMicro↑, 12,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 1,  
Total Targets: 369

Scientific Paper Hit Count for: angioG, angiogenesis
14 Magnetic Fields
14 Thymoquinone
12 itraconazole
11 Curcumin
11 Chrysin
11 Sulforaphane (mainly Broccoli)
9 Fisetin
9 Fucoidan
9 MCT, metronomic chemo
9 Resveratrol
9 Silymarin (Milk Thistle) silibinin
8 Artemisinin
8 Propolis -bee glue
8 Copper and Cu NanoParticles
8 Kaempferol
8 Quercetin
8 Luteolin
7 Ashwagandha(Withaferin A)
7 Betulinic acid
7 Cinnamon
7 Radiotherapy/Radiation
7 Eugenol
7 Nimbolide
6 Benzyl isothiocyanate
6 Phenethyl isothiocyanate
6 Capsaicin
5 Silver-NanoParticles
5 Apigenin (mainly Parsley)
5 Berberine
5 chitosan
5 Ellagic acid
5 EGCG (Epigallocatechin Gallate)
5 Formononetin
5 Gambogic Acid
5 Magnolol
5 Melatonin
5 Selenite (Sodium)
4 immunotherapy
4 Beta-Caryophyllene
4 Boswellia (frankincense)
4 Rosmarinic acid
4 Celastrol
4 D-limonene
4 Disulfiram
4 Isoliquiritigenin
4 Lycopene
3 Isothiocyanates
3 Carvacrol
3 Chlorogenic acid
3 Hydroxycinnamic-acid
3 Coenzyme Q10
3 Crocetin
3 Dichloroacetate
3 Emodin
3 Ferulic acid
3 Gallic acid
3 phytic acid, Inositol hexakisphosphate
3 Ivermectin
3 Juglone
3 mebendazole
3 methylseleninic acid
3 Piperlongumine
3 Spirulina(Arthrospira/Limnospira)
3 tetrathiomolybdate
2 3-bromopyruvate
2 chemodynamic therapy
2 Allyl isothiocyanate
2 Allicin (mainly Garlic)
2 Alpha-Lipoic-Acid
2 Chemotherapy
2 beta-glucans
2 Baicalein
2 Boron
2 Caffeic acid
2 Carnosic acid
2 chaetocin
2 Carica papaya leaf extract
2 Cucurbitacin
2 Deguelin
2 Diclofenac
2 Dipyridamole
2 Dandelion Root
2 Ginkgo biloba-EGb 761
2 Flaxseed/Linseed
2 Garcinol
2 Ginkgolide B
2 Helleborus niger extracts – Christmas Rose
2 Honokiol
2 HydroxyTyrosol
2 isoflavones
2 Isovitexin
2 Licochalcone A
2 SDG/lignans
2 Linalool
2 Modified Citrus Pectin
2 Mangiferin
2 Mistletoe/Viscum album Extracts
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Naringin
2 Phycocyanin
2 Piperine
2 Propranolol
2 Pterostilbene
2 α-Santalol/Sandalwood oil
2 Selenium
2 Selenium NanoParticles
2 Ursolic acid
2 Zyflamend
1 Annona atemoya Seed Extract
1 Auranofin
1 Astragalus
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Andrographis
1 Anethole/trans-Anethole
1 Aspirin
1 Ascorbyl Palmitate
1 Atorvastatin
1 Aloe anthraquinones
1 Biochanin A
1 Bufalin/Huachansu
1 borneol
1 Beetroot
1 Black turtle bean
1 urea
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Sorafenib (brand name Nexavar)
1 Carnosine
1 Celecoxib
1 Centella asiatica / Gotu kola → asiaticoside
1 Chocolate
1 Metformin
1 Cimetidine
1 Citric Acid
1 Vitamin E
1 diet FMD Fasting Mimicking Diet
1 diet Ketogenic
1 Diindolylmethane
1 Zinc
1 Echinacea
1 Electrical Pulses
1 flavonoids
1 olaparib/LYNPARZA
1 Ginkgo biloba
1 Genistein (soy isoflavone)
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginkgetin
1 Gossypol/AT-101
1 Hydrogen Gas
1 hydrogen sulfide
1 Hibiscus sabdariffa
1 Hops (Humulus lupulus)
1 Isorhamnetin
1 isoorientin
1 Vitexin
1 low dose naltrexone
1 Docetaxel
1 Matrine
1 Sulindac
1 Paclitaxel/Taxol
1 Methyl Jasmonate
1 vp16, etoposide
1 Magnetic Field Rotating
1 Lemon Balm/Melissa officinalis
1 Neem
1 Oroxylin-A
1 Oleuropein
1 Oleocanthal
1 Marjoram (Origanum majorana)
1 Oregano
1 Phenylbutyrate
1 Purple Corn / Purple Maize
1 Plumbagin
1 Pomi-T
1 Psoralidin
1 Ramucirumab (CYRAMZA)
1 Rutin
1 buckwheat sprouts
1 Salvia officinalis
1 salinomycin
1 Sesamin
1 Shikonin
1 Theobromine
1 Aflavin-3,3′-digallate
1 Thymol-Thymus vulgaris
1 Urolithin
1 Usnic acid
1 Vitamin C (Ascorbic Acid)
1 Vitamin D3
1 Walnut
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:447  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page